Effects of retinoic acid on human hepatocarcinoma cell lines apoptosis
Han Sheng-x
Abstract
Han Sheng-x
Abstract
Objective To investgate the growth inhibition and apoptosis induced by all-trans-retinoic acid (ATRA), and its possible molecular mechanism in human hepatocarcinoma cell lines. Methods Human hepatocarcinoma cell lines SMMC-7721 were cultured with ATRA at the concentration of 0.5μg/ml for 4 days. The cells apoptosis and growth inhibition were assessed by cytomorphology and counting the number of cells to calculate the rate of growth-inhibited. Cell cycle, tumor associated genes p53, Fas and Bcl-2 were analyzed with flow cytometry.Results ATRA inhibited the growth of hepatocarcinoma cells SMMC-7721 in vitro. Apoptosis cells of total cells were 16% compared with control 6.9% (P0.01) and a sub-G 1 phase cell peak was observed. Morphological observation with light microscope revealed apoptosis feature, i.e. chromatin condensation, nucleus fragmentation and cytoplasmic blebbing. There was a significant different rate of growth-inhibited between the two groups.(P0.005). The expression of p53 and Fas were up-regulated, and Bcl-2 was down-regulated when treated with ATRA in contrast to control.Conclusion ATRA can induce human hepatocarcinoma cell apoptosis. It could be a potential therapeutic agent for hepatocarcinoma. Tumor associated genes such as p53, Fas and Bcl-2 may be involved in molecular mechanism of ATRA effects.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investgate the growth inhibition and apoptosis induced by all-trans-retinoic acid (ATRA), and its possible molecular mechanism in human hepatocarcinoma cell lines. Methods Human hepatocarcinoma cell lines SMMC-7721 were cultured with ATRA at the concentration of 0.5μg/ml for 4 days. The cells apoptosis and growth inhibition were assessed by cytomorphology and counting the number of cells to calculate the rate of growth-inhibited. Cell cycle, tumor associated genes p53, Fas and Bcl-2 were analyzed with flow cytometry.Results ATRA inhibited the growth of hepatocarcinoma cells SMMC-7721 in vitro. Apoptosis cells of total cells were 16% compared with control 6.9% (P0.01) and a sub-G 1 phase cell peak was observed. Morphological observation with light microscope revealed apoptosis feature, i.e. chromatin condensation, nucleus fragmentation and cytoplasmic blebbing. There was a significant different rate of growth-inhibited between the two groups.(P0.005). The expression of p53 and Fas were up-regulated, and Bcl-2 was down-regulated when treated with ATRA in contrast to control.Conclusion ATRA can induce human hepatocarcinoma cell apoptosis. It could be a potential therapeutic agent for hepatocarcinoma. Tumor associated genes such as p53, Fas and Bcl-2 may be involved in molecular mechanism of ATRA effects.
Key concepts: Apoptosis, Retinoic acid, Flow cytometry, Cell cycle, Growth inhibition, Molecular biology, Cell growth, Fragmentation (computing)